Tags

Type your tag names separated by a space and hit enter

Provider-verified HPV vaccine coverage among a national sample of Hispanic adolescent females.
Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):742-54.CE

Abstract

BACKGROUND

Hispanic females have the highest cervical cancer incidence rate of any racial or ethnic group in the United States, yet relatively little research has examined human papillomavirus (HPV) vaccination among this fast-growing population. We examined HPV vaccination among a national sample of Hispanic adolescent females.

METHODS

We analyzed provider-verified vaccination data from the 2010-2011 National Immunization Survey-Teen for Hispanic females ages 13 to 17 years (n = 2,786). We used weighted logistic regression to identify correlates of HPV vaccine initiation (receipt of one or more doses), completion (receipt of three doses), and follow-through (receipt of three doses among those who initiated the series).

RESULTS

HPV vaccine initiation was 60.9%, completion was 36.0%, and follow-through was 59.1%. Initiation and completion were more common among older daughters and those whose parents had received a provider recommendation to vaccinate (all P < 0.05). Completion was less common among daughters who had moved from their birth state (P < 0.05). All vaccination outcomes were less common among daughters without health insurance (all P < 0.05). Vaccination did not differ by parents' preferred language (all P > 0.05), although intent to vaccinate was higher among Spanish-speaking parents (P < 0.01). Spanish-speaking parents were more likely to indicate lack of provider recommendation (20.2% vs. 5.3%) and cost (10.9% vs. 1.8%) as main reasons for not intending to vaccinate (both P < 0.05).

CONCLUSIONS

Many Hispanic females have not received HPV vaccine. Several factors, including provider recommendation and health insurance, are key correlates of vaccination.

IMPACT

HPV vaccination programs targeting Hispanics are needed and should consider how potential barriers to vaccination may differ by preferred language.

Authors+Show Affiliations

Authors' Affiliations: Division of Cancer Prevention and Control, College of Medicine; Comprehensive Cancer Center; College of Public Health, The Ohio State University, Columbus, Ohio; UNC Gillings School of Global Public Health; and Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

24633142

Citation

Reiter, Paul L., et al. "Provider-verified HPV Vaccine Coverage Among a National Sample of Hispanic Adolescent Females." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored By the American Society of Preventive Oncology, vol. 23, no. 5, 2014, pp. 742-54.
Reiter PL, Gupta K, Brewer NT, et al. Provider-verified HPV vaccine coverage among a national sample of Hispanic adolescent females. Cancer Epidemiol Biomarkers Prev. 2014;23(5):742-54.
Reiter, P. L., Gupta, K., Brewer, N. T., Gilkey, M. B., Katz, M. L., Paskett, E. D., & Smith, J. S. (2014). Provider-verified HPV vaccine coverage among a national sample of Hispanic adolescent females. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored By the American Society of Preventive Oncology, 23(5), 742-54. https://doi.org/10.1158/1055-9965.EPI-13-0979
Reiter PL, et al. Provider-verified HPV Vaccine Coverage Among a National Sample of Hispanic Adolescent Females. Cancer Epidemiol Biomarkers Prev. 2014;23(5):742-54. PubMed PMID: 24633142.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Provider-verified HPV vaccine coverage among a national sample of Hispanic adolescent females. AU - Reiter,Paul L, AU - Gupta,Kunal, AU - Brewer,Noel T, AU - Gilkey,Melissa B, AU - Katz,Mira L, AU - Paskett,Electra D, AU - Smith,Jennifer S, Y1 - 2014/03/14/ PY - 2014/3/18/entrez PY - 2014/3/19/pubmed PY - 2014/12/23/medline SP - 742 EP - 54 JF - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology JO - Cancer Epidemiol Biomarkers Prev VL - 23 IS - 5 N2 - BACKGROUND: Hispanic females have the highest cervical cancer incidence rate of any racial or ethnic group in the United States, yet relatively little research has examined human papillomavirus (HPV) vaccination among this fast-growing population. We examined HPV vaccination among a national sample of Hispanic adolescent females. METHODS: We analyzed provider-verified vaccination data from the 2010-2011 National Immunization Survey-Teen for Hispanic females ages 13 to 17 years (n = 2,786). We used weighted logistic regression to identify correlates of HPV vaccine initiation (receipt of one or more doses), completion (receipt of three doses), and follow-through (receipt of three doses among those who initiated the series). RESULTS: HPV vaccine initiation was 60.9%, completion was 36.0%, and follow-through was 59.1%. Initiation and completion were more common among older daughters and those whose parents had received a provider recommendation to vaccinate (all P < 0.05). Completion was less common among daughters who had moved from their birth state (P < 0.05). All vaccination outcomes were less common among daughters without health insurance (all P < 0.05). Vaccination did not differ by parents' preferred language (all P > 0.05), although intent to vaccinate was higher among Spanish-speaking parents (P < 0.01). Spanish-speaking parents were more likely to indicate lack of provider recommendation (20.2% vs. 5.3%) and cost (10.9% vs. 1.8%) as main reasons for not intending to vaccinate (both P < 0.05). CONCLUSIONS: Many Hispanic females have not received HPV vaccine. Several factors, including provider recommendation and health insurance, are key correlates of vaccination. IMPACT: HPV vaccination programs targeting Hispanics are needed and should consider how potential barriers to vaccination may differ by preferred language. SN - 1538-7755 UR - https://www.unboundmedicine.com/medline/citation/24633142/Provider_verified_HPV_vaccine_coverage_among_a_national_sample_of_Hispanic_adolescent_females_ L2 - http://cebp.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=24633142 DB - PRIME DP - Unbound Medicine ER -